Richard Adcock

Insider Reports History

Entity
Individual
Location
C/O Immunitybio, Inc., 3530 John Hopkins Court, San Diego, CA
Signature
/s/ Jason Liljestrom, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Richard Adcock:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ImmunityBio, Inc. CEO & President, Director Common Stock 334K $1.14M $3.42 Feb 22, 2025 Direct
ImmunityBio, Inc. CEO & President, Director Restricted Stock Units 305K $1.04M $3.42 Feb 22, 2025 Direct
ImmunityBio, Inc. CEO & President, Director Stock Option (right to buy) 2.81M Feb 10, 2025 Direct

Insider Reports Filed by Richard Adcock

Symbol Company Period Transactions Value $ Form Type Date Filed Role
IBRX ImmunityBio, Inc. Feb 22, 2025 3 -$267K 4 Feb 25, 2025 CEO & President, Director
IBRX ImmunityBio, Inc. Feb 10, 2025 2 $0 4 Feb 12, 2025 CEO & President, Director
IBRX ImmunityBio, Inc. Dec 31, 2024 3 -$44.7K 4 Jan 3, 2025 CEO & President, Director
IBRX ImmunityBio, Inc. Feb 22, 2024 2 $0 4 Feb 26, 2024 CEO & President, Director
IBRX ImmunityBio, Inc. Feb 5, 2024 3 -$174K 4 Feb 6, 2024 CEO & President, Director
IBRX ImmunityBio, Inc. Dec 31, 2023 3 -$85.8K 4 Jan 3, 2024 CEO & President, Director
IBRX ImmunityBio, Inc. Feb 5, 2023 3 -$183K 4 Feb 7, 2023 CEO & President, Director
IBRX ImmunityBio, Inc. Dec 31, 2022 3 -$21.7K 4 Jan 4, 2023 CEO & President, Director
IBRX ImmunityBio, Inc. Mar 23, 2022 2 $0 4 Mar 25, 2022 CEO & President, Director
IBRX ImmunityBio, Inc. Feb 5, 2022 3 -$159K 4 Feb 8, 2022 CEO & President, Director
IBRX ImmunityBio, Inc. Oct 8, 2021 2 $17K 4 Oct 8, 2021 CEO & President, Director
IBRX ImmunityBio, Inc. Sep 9, 2021 3 -$42.5K 4 Sep 13, 2021 Chief Executive Officer, Director